Roche Holding AG
RHO5
Company Profile
Business description
Roche is a Swiss biopharmaceutical and diagnostic company. The firm's bestselling pharmaceutical products include a variety of oncology therapies from acquired partner Genentech, and its diagnostics group was bolstered by the acquisition of Ventana in 2008. Oncology products account for 50% of pharmaceutical sales, and centralized and point-of-care diagnostics for more than half of diagnostic-related sales.
Contact
Grenzacherstrasse 124
Basel4070
CHET: +41 616881111
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - General
Fiscal Year End
31 December 2025
Employees
103,249
Stocks News & Analysis
stocks
Magnificent Seven vs. the ‘Granolas’: How does Europe’s version stack up?
‘Granolas’ stocks are profitable, diversified, cheap—and posting big returns.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,013.70 | 8.20 | -0.10% |
| CAC 40 | 7,326.47 | 40.61 | 0.56% |
| DAX 40 | 21,293.53 | 87.67 | 0.41% |
| Dow JONES (US) | 38,827.33 | 656.92 | 1.72% |
| FTSE 100 | 8,328.60 | 52.94 | 0.64% |
| HKSE | 21,562.32 | 167.18 | 0.78% |
| NASDAQ | 16,178.39 | 307.49 | 1.94% |
| Nikkei 225 | 34,220.60 | 59.32 | -0.17% |
| NZX 50 Index | 11,836.69 | 282.30 | -2.33% |
| S&P 500 | 5,243.58 | 85.38 | 1.66% |
| S&P/ASX 200 | 7,816.70 | 2.40 | -0.03% |
| SSE Composite Index | 3,299.76 | 8.32 | 0.25% |